# Alternative treatment approaches for ANCA-associated vasculitis
Biological therapies beyond standard regimens
In ANCA vasculitis, targeted biological agents are increasingly being investigated alongside conventional corticosteroids and cyclophosphamide. These act on specific components of the immune system.
**Mepolizumab (anti-IL-5 antibody)
**
Label: **
Under investigation
Mepolizumab is an antibody that specifically targets eosinophilic inflammatory cells and has been particularly investigated in eosinophilic granulomatosis with polyangiitis (EGPA), one form of ANCA vasculitis. Studies show that certain patients respond better to this agent than others, possibly depending on genetic differences. This type of 'personalized' approach is still in development. The agent is administered intravenously and may benefit patients for whom standard treatment is insufficiently effective or causes severe side effects. The place of mepolizumab in the treatment regimen has not yet been definitively established and varies by hospital institution.
**Rituximab (B-cell depletion)
**
Label: **
Under investigation
Rituximab destroys B-cells, immune cells involved in the inflammatory response. Studies show that this agent can be effective for remission induction (halting disease progression) and may be equivalent to cyclophosphamide with fewer long-term side effects. It is usually administered intravenously. Rituximab has the advantage of acting specifically on one component of the immune abnormality, but has not yet been included as standard in all guidelines.
Chinese herbal treatment
Label: **Unproven**
Some case reports have been described in which patients with microscopic polyangiitis (a form of ANCA vasculitis) achieved remission following traditional Chinese herbal treatment, sometimes in combination with standard therapy. These findings are currently limited to individual patient reports and have not been systematically investigated in larger study populations. It is unclear which active compounds would be effective, how these interact with regular medications, or whether remission can be attributed to the herbs or to standard treatment. Patients considering this should always inform their doctor, as many herbal mixtures interfere with anticoagulants and other medications.
Complementary and alternative medicine (CAM) in general
Label: **Unproven**
Research into the use of complementary agents (nutritional supplements, acupuncture, homeopathy, aromatherapy and more) shows that many patients with ANCA vasculitis use these alongside their regular treatment, usually without discussing this with their doctor. This is an important finding because:
- Many supplements (especially those with high doses of vitamins, herbs with anti-inflammatory reputation, or agents to 'support immunity') can interact with corticosteroids and immunosuppressants.
- Some herbal mixtures affect the action of medications that thin the blood or combat inflammation.
- There is a risk that patients reduce or discontinue their regular treatment believing that complementary agents are sufficient.
To date, rigorous studies demonstrating that specific CAM modalities improve disease or remission are lacking. Many patients do report benefits from relaxation techniques (yoga, meditation) for coping with chronic illness and stress, but this works at a psychological level, not on inflammation itself.
Immune modulators under investigation
Label: **Experimental**
New research points to ways to favorably influence certain regulatory cells (such as Th17-associated regulatory cells). This concerns experimental approaches that have not yet been introduced into clinical practice. The underlying idea is that the immune dysfunction in ANCA-vasculitis consists not only of too many inflammatory cells, but also of a disruption in the body's natural inhibitory mechanisms. Future treatments could restore this regulation, but this is still in the research stage.
Why alternative therapies should be approached with caution
ANCA-vasculitis is a serious, potentially life-threatening disease in which regular treatment (corticosteroids and immunosuppressants) is crucial for preventing organ damage, especially to the kidneys and airways. Withholding or replacing this treatment with unproven remedies can have serious consequences. Furthermore:
- Many alternative remedies are weakly regulated; composition and purity can be uncertain.
- Interactions with immunosuppressants are insufficiently known in many cases.
- Patients sometimes feel more guilty or responsible for their illness when using alternative remedies, which can be psychologically burdensome.
What research is still needed
In the coming years, research will likely focus on:
- Further optimization of biological therapies and their combinations.
- Identification of genetic and biological markers that predict who responds best to which agent (personalized medicine).
- Safety profiles of long-term use of immunosuppressants, so patients can opt for the least burdensome regimen.
Until then, standard treatment (initial corticosteroids and immunosuppressants, followed by maintenance therapy) remains the cornerstone of treatment.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._